文献速递腹部技术与安全US

多参数超声指标与代谢相关脂肪性肝病患者病理状态之间的关联

Associations Between Multiparametric US-Based Indicators and Pathological Status in Patients with Metabolic Associated Fatty Liver Disease.
PubMed 文献 · Ultrasound Med Biol · 2024-06-12

前瞻性纳入2020年12月至2022年9月接受肝活检和多参数超声的116例代谢相关脂肪性肝病患者,分析衰减系数、肝硬度与色散斜率同脂肪变分级、炎症分级及纤维化分期的关系;衰减系数可区分脂肪变分级,肝硬度仅与纤维化分期相关,色散斜率与纤维化及炎症分级均相关。

要点

  • 衰减系数在区分脂肪变分级时AUC为0.82~0.84,但不反映炎症或纤维化。
  • 肝硬度区分纤维化分期AUC为0.83~0.95,仅由纤维化分期决定,与炎症分级无关。
  • 色散斜率区分炎症分级AUC为0.79~0.81、纤维化分期AUC为0.80~0.88。

核心结论

  • 衰减系数提示肝脂肪变程度但不提示炎症或纤维化;肝硬度仅由纤维化分期决定且与炎症分级无关;色散斜率与纤维化和炎症分级均相关。

研究设计与样本

  • 前瞻性研究,纳入2020年12月至2022年9月接受肝活检和多参数超声的116例代谢相关脂肪性肝病患者,获取衰减系数、肝硬度和色散斜率三项超声参数,以肝活检病理为参考标准。

关键影像表现/征象

  • 衰减系数值在不同脂肪变分级之间差异有统计学意义(p < 0.001)。
  • 色散斜率和肝硬度值在炎症分级(p < 0.001)和纤维化分期(p < 0.001)之间均有差异。
  • 亚组分析显示肝硬度在炎症分级中呈不同趋势,但在纤维化分期中跨亚组趋势一致。
  • 亚组分析显示色散斜率在炎症分级和纤维化分期中跨所有亚组趋势均一致。

诊断标准与关键数值

  • 衰减系数区分脂肪变分级的AUC为0.82~0.84。
  • 肝硬度区分炎症分级的AUC为0.62~0.76,区分纤维化分期的AUC为0.83~0.95。
  • 色散斜率区分炎症分级的AUC为0.79~0.81,区分纤维化分期的AUC为0.80~0.88。

临床应用与阅片要点

  • 测量衰减系数可用于评估肝脂肪变分级,但不能据其推断炎症分级或纤维化分期。
  • 肝硬度值升高应主要对应纤维化分期,原文显示其与炎症分级无关。
  • 色散斜率可同时反映炎症分级和纤维化分期,且跨亚组趋势一致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Noninvasive evaluation of metabolic dysfunction-associated fatty liver disease (MAFLD) using ultrasonography holds significant clinical value. The associations between ultrasound (US)-based parameters and the pathological spectra remain unclear and controversial. This study aims to investigate the associations thoroughly.

METHODS: The participants with MAFLD undergoing liver biopsy and multiparametric ultrasonography were prospectively recruited from December 2020 to September 2022. Three US-based parameters, namely attenuation coefficient (AC), liver stiffness (LS) and dispersion slope (DS) were obtained. The relationship between these parameters and steatosis grades, inflammation grades and fibrosis stages was examined.

RESULTS: In this study with 116 participants, AC values significantly differed across distinct steatosis grades (p < 0.001), while DS and LS values varied among inflammation grades (p < 0.001) and fibrosis stages (p < 0.001). The area under the receiver operating characteristic curves (AUCs) of AC ranged from 0.82 to 0.84 for differentiating steatosis grades, while AUCs of LS ranged from 0.62 to 0.76 for distinguishing inflammation grades and 0.83-0.95 for discerning fibrosis stages. AUCs for DS ranged from 0.79 to 0.81 in discriminating inflammation grades and 0.80-0.88 for differentiating fibrosis stages. Subgroup analysis revealed that LS demonstrated different trends in inflammation grade but consistent trends in fibrosis stage across subgroups, whereas DS showed consistent trends for both inflammation grade and fibrosis stage across all subgroups.

CONCLUSION: AC values indicate the degree of hepatic steatosis but not inflammation or fibrosis. LS values are determined only by fibrosis stage and are not associated with inflammation grades. DS values are associated with both fibrosis and inflammation grades.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Zhou Y, Nie M, Mao F, et al. Associations Between Multiparametric US-Based Indicators and Pathological Status in Patients with Metabolic Associated Fatty Liver Disease. Ultrasound Med Biol. 2024. PMID: 38871490. doi:10.1016/j.ultrasmedbio.2024.05.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。